Clinical research is a critical component in the pet drug development process, helping us better understand the safety, efficacy, optimal dosage or treatment plans, and potential side effects of pet drugs. With years of dedication to the pet health industry, Protheragen Vetivio deeply recognizes the complexities of clinical research for pet drugs. We offer clients ethically compliant, one-stop clinical research services for pet drugs, ensuring safety and effectiveness, and accelerating time to market. If you are seeking a reliable clinical research partner, please feel free to contact us.
Protheragen Vetivio boasts a professional team, extensive experience, and global resources to provide comprehensive clinical research services. We have extensive clinical trial experience in a wide range of pet disease areas, covering common conditions in dogs and cats (such as dermatology and osteoarthritis) as well as complex specialized diseases (such as oncology and endocrine disorders). Our clinical research services adhere to strict international standards, ensuring scientifically reliable clinical data support for pet drug development.
Clinical Feasibility Study
Phase II Clinical Trial
Clinical Monitoring
Biostatistics
Clinical Trial Protocol Design
Phase III Clinical Trial
Drug Pharmacovigilance
Medical Writing
Phase I Clinical Trial
Phase IV Clinical Trial
Clinical Data Management
Others
We are committed to developing safer and more effective drugs for a wide range of pet diseases through rigorous, scientific clinical research. Our clinical research covers a wide range of common pet diseases, including but not limited to:
Oncology
Parasitic Infections
Urinary Tract Infections
Arthritis
Atopic Dermatitis
Gastroenteritis
Cardiomyopathy
Cataracts
Fungal Infections
Chronic Kidney Disease
Diabetes Mellitus
Others
Conjunctivitis
Periodontal Disease
Glaucoma
Experienced Pet Drug Clinical Team
Our core team has years of extensive experience in clinical research with dogs, cats, and other companion animals. With a deep understanding of their unique physiological, pathological, and behavioral characteristics, as well as common disease models, we can accurately grasp the key aspects of each phase of clinical trials, ensuring the scientific and efficient completion of clinical studies.
Strict Quality System
We have established a comprehensive quality management system that meets international standards and strictly adheres to GCP regulations and animal welfare ethics. Through standard operating procedures, systematic training, and multi-level quality audits, ensure the authenticity and reliability of research data and results, meeting the technical requirements of global regulatory agencies.
One-Stop Service
We provide comprehensive services from early clinical research to post-marketing surveillance, encompassing protocol design, clinical trials, data analysis, report writing, and pharmacovigilance. This one-stop service significantly reduces client communication costs and accelerates the pet drug development process.
Efficient Project Execution
Through meticulous project management and proactive risk management, combined with extensive clinical research resources and exceptional resource allocation capabilities, we can ensure the rapid initiation and efficient completion of clinical studies, significantly shortening project cycles and gaining valuable time for clients.